Asahi Kasei Life Science at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

Asahi Kasei Life Science brings 1 presentation to ESGCT 2026 in Hamburg. Its contribution covers pathogen safety in cell and gene therapy manufacturing, centred on virus filtration. The work sets out how to fit a virus-removal filtration step into the making of these products.

OrganizationESGCT 2026 Attendance
◇Bronze Sponsor
asahikaseibioprocess.planova.ak-bio.com/ESGCT2025_akb_top
Tools & reagentsBronze Sponsor
Supplies bioprocessing products, including Planova virus-removal filters, plus virus and mycoplasma safety testing for biologic and cell and gene therapy manufacturing.
Poster
Thu Oct 29
2:00pm–4:00pm
Implementing Virus Filtration to Ensure Pathogen Safety of Cell and Gene Therapy Products
Manufacturing

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Asahi Kasei Life Science

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction